We are live on ! Find out more
JSAM

J. Safra Asset Management Portfolio holdings

AUM $2.17B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+29.66%
3 Year Est. Return
+84.26%
5 Year Est. Return
+107.54%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
+$354K
Cap. Flow
+$54.9M
Cap. Flow %
4.46%
Top 10 Hldgs %
68.41%
Holding
404
New
63
Increased
215
Reduced
43
Closed
59

Top Buys

Rank Stock Value
1
AAXJ icon
iShares MSCI All Country Asia ex Japan ETF
AAXJ
+$55.8M
2
MAGS icon
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
+$19.1M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$8.05M
4
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$4.87M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.77M

Top Sells

Rank Stock Value
1
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$5.73M
3
IWB icon
iShares Russell 1000 ETF
IWB
+$3.56M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$2.37M
5
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$1.3M

Sector Composition

Rank Sector Weight
1 Technology 2.22%
2 Communication Services 1.07%
3 Financials 0.88%
4 Consumer Discretionary 0.82%
5 Healthcare 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLTX icon
326
MoonLake Immunotherapeutics
MLTX
$1.41B
$1.99K ﹤0.01%
51
+43
+538% +$1.85K
RVMD icon
327
Revolution Medicines
RVMD
$44.1B
$1.8K ﹤0.01%
51
+43
+538% +$1.75K
JANX icon
328
Janux Therapeutics
JANX
$1.01B
$1.78K ﹤0.01%
66
+56
+560% +$2.11K
COGT icon
329
Cogent Biosciences
COGT
$6.61B
$1.59K ﹤0.01%
+266
New +$2.09K
VCYT icon
330
Veracyte
VCYT
$3.73B
$1.54K ﹤0.01%
+52
New +$1.98K
RNAM
331
DELISTED
Avidity Biosciences
RNAM
$1.51K ﹤0.01%
51
+43
+538% +$1.34K
SYK icon
332
Stryker
SYK
$134B
$1.49K ﹤0.01%
4
– –
NRIX icon
333
Nurix Therapeutics
NRIX
$2.69B
$1.15K ﹤0.01%
97
+82
+547% +$1.37K
GILD icon
334
Gilead Sciences
GILD
$168B
$1.01K ﹤0.01%
9
+5
+125% +$516
CVS icon
335
CVS Health
CVS
$120B
$881 ﹤0.01%
13
-3,000
-100% -$180K
INSP icon
336
Inspire Medical Systems
INSP
$1.71B
$796 ﹤0.01%
5
– –
GKOS icon
337
Glaukos
GKOS
$10.7B
$787 ﹤0.01%
8
– –
FTRE icon
338
Fortrea Holdings
FTRE
$1.86B
$785 ﹤0.01%
104
-590
-85% -$8.33K
SLNO
339
DELISTED
Soleno Therapeutics
SLNO
$500 ﹤0.01%
+7
New +$341
NUVL
340
DELISTED
Nuvalent
NUVL
$496 ﹤0.01%
7
– –
BRKR icon
341
Bruker
BRKR
$8.69B
$459 ﹤0.01%
11
– –
WST icon
342
West Pharmaceutical
WST
$24.7B
$448 ﹤0.01%
+2
New +$551
IRON icon
343
Disc Medicine
IRON
$3.12B
$298 ﹤0.01%
+6
New +$334
OXY.WS icon
344
Occidental Petroleum Corp Warrants
OXY.WS
$34.8B
$111 ﹤0.01%
4
– –
EXC icon
345
Exelon
EXC
$46.2B
$39 ﹤0.01%
1
-1,601
-100% -$66.9K
APG icon
346
APi Group
APG
$18.5B
– –
-9,945
Closed -$239K
AWI icon
347
Armstrong World Industries
AWI
$7.89B
– –
-134
Closed -$19K
BPMC
348
DELISTED
Blueprint Medicines
BPMC
– –
-5
Closed -$434
CIVI
349
DELISTED
Civitas Resources
CIVI
– –
-446
Closed -$19.9K
CNM icon
350
Core & Main
CNM
$8.73B
– –
-391
Closed -$20.3K
12 13
14
15 16

Similar funds

ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

J. Safra Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, J. Safra Asset Management held 404 positions worth $1.23B, up 0.03% from $1.23B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

J. Safra Asset Management deployed $54.9M of net new capital in Q1 2025, opening 63 new positions and adding to 215 existing holdings. Its largest new stake was iShares MSCI All Country Asia ex Japan ETF: 754,260 shares worth $55.8M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 1.7% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $73.5M trimmed.

  • J. Safra Asset Management's largest Q1 2025 buy was iShares MSCI All Country Asia ex Japan ETF: 754,260 shares worth $55.8M.
  • J. Safra Asset Management added most to Listed Funds Trust Roundhill Magnificent Seven ETF in Q1 2025, an estimated $19.1M increase.
  • J. Safra Asset Management's biggest Q1 2025 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $73.5M.
  • J. Safra Asset Management fully exited Vanguard S&P 500 ETF in Q1 2025, selling an estimated $5.73M.
  • J. Safra Asset Management's ten largest holdings make up 68% of its $1.23B portfolio in Q1 2025.
  • J. Safra Asset Management opened 63 new positions and closed 59 in Q1 2025.
  • J. Safra Asset Management's portfolio value rose 0.03% quarter-over-quarter to $1.23B.

Based on J. Safra Asset Management's 13F filing for Q1 2025, filed 25 Apr 2025.